Generix Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.
2007 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Generix Lifesciences Private Limited

Generix Lifesciences Private Limited, a active private limited company, was established on 13 June 2007 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24110DL2007PTC164689. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.00 Cr.

It upholds a compliant status. Employing 4 professional, Its leadership includes Rekha Jha (Director), Sandeep Jha (Director). Past directors included Vinod Nair, Rekha Jha, Ramesh Rajan. It holds ₹8.90 Cr open charges and ₹13.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ground Floor 207 Shahpur Jat, New Delhi, Delhi, 110049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110DL2007PTC164689

  • Registration Number

    164689

  • Incorporation Date

    13 June 2007

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 18 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 8.90 Cr
  • Satisfied Charges ₹ 13.48 Cr
  • Revenue Growth **** -17.01%
  • Profit Growth **** 44.52%
  • Ebitda **** 37.23%
  • Net Worth -36.85%
  • Total Assets -10.91%
Company report

Generix Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Generix Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Generix Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Rekha Jha Director 26 Nov 2020 Current
Sandeep Jha Director 13 Jun 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Nov 2020 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 09 Jun 2015 Past
Pramod Abcsdd Director 05 Mar 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Generix Lifesciences.

Generix Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.01% decrease. The company also saw a substantial improvement in profitability, with a 44.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.85%.

Generix Lifesciences revenue growth over time
Generix Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.01%
*******
*******
*******
*******
Revenue from Operations
*******
 -50.32%
*******
*******
*******
*******
Total Assets
*******
 -10.91%
*******
*******
*******
*******
Profit or Loss
*******
 44.52%
*******
*******
*******
*******
Net Worth
*******
 -36.85%
*******
*******
*******
*******
EBITDA
*******
 37.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Generix Lifesciences?

Unlock access to Generix Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹89,000,000.00

Satisfied Charges

₹134,779,000.00

Charges Breakdown by Lending Institutions
  • Others : 9.95 Cr
  • Edelweiss Retail Finance Limited : 3.00 Cr
  • Kotak Mahindra Bank Limited : 0.53 Cr
Latest Charge Details
Date Lender Amount Status
25 Aug 2017 Others ₹8.90 Cr Satisfied
27 Jun 2016 Others ₹1.05 Cr Satisfied
29 Jan 2015 Edelweiss Retail Finance Limited ₹1.87 Cr Satisfied
29 Nov 2014 Edelweiss Retail Finance Limited ₹1.13 Cr Satisfied
28 Sep 2010 Kotak Mahindra Bank Limited ₹5.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Generix Lifesciences?

Generix Lifesciences has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Generix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generix Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Generix Lifesciences
Recent Activity within the Organization
  • Charges

    A charge registered on 25 Aug 2017 via Charge ID 100122192 with Others was fully satisfied on 03 Jan 2025. was recorded as a recent event.

  • Annual General Meeting

    Generix Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Generix Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 8.90 Cr registered on 25 Aug 2017 with Charge ID 100122192 was modified on 11 Feb 2021. was documented.

  • Director Appointment

    The activity Rekha Jha was appointed as a Director was appointed as a Director on 26 Nov 2020 & has been associated with this company since 5 years 2 months . was completed.

  • Charges

    A charge registered on 27 Jun 2016 via Charge ID 100043629 with Others was fully satisfied on 06 Nov 2017. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Generix Lifesciences Private Limited?

The CIN of Generix Lifesciences Private Limited is U24110DL2007PTC164689.

Where is Generix Lifesciences Private Limited headquartered?

Generix Lifesciences Private Limited is headquartered at Ground Floor 207 Shahpur Jat, New Delhi, Delhi, 110049.

When was Generix Lifesciences Private Limited incorporated?

Generix Lifesciences Private Limited was incorporated on 13 June 2007.

Who are the current directors of Generix Lifesciences Private Limited?

The current directors of Generix Lifesciences Private Limited are

What is the primary industry of Generix Lifesciences Private Limited?

The primary industry of Generix Lifesciences Private Limited is Trade.

Is Generix Lifesciences Private Limited a listed company?

Generix Lifesciences Private Limited is unlisted.

What is the capital structure of Generix Lifesciences Private Limited?

The authorized capital of Generix Lifesciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.00 Cr.

What is the compliance status of Generix Lifesciences Private Limited?

The compliance status of Generix Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available